Association of two DRD2 gene polymorphisms with acute and tardive antipsychotic-induced movement disorders in young Caucasian patients.

Saved in:
Bibliographic Details
Title: Association of two DRD2 gene polymorphisms with acute and tardive antipsychotic-induced movement disorders in young Caucasian patients.
Authors: Koning, Jeroen, Vehof, Jelle, Burger, Huibert, Wilffert, Bob, Hadithy, Asmar, Alizadeh, Behrooz, Harten, Peter, Snieder, Harold
Source: Psychopharmacology. Feb2012, Vol. 219 Issue 3, p727-736. 10p.
Subjects: Pharmacogenomics, Serotonin, Dopamine, Schizophrenia, Movement disorders, Antipsychotic agents, Genetic polymorphisms, White people, Health
Abstract: Rationale: Pharmacogenetic studies on antipsychotic-induced movement disorders (MD) in schizophrenia so far have focused mainly on tardive dyskinesia. Only a few examined the more acute antipsychotic-induced MD such as parkinsonism and akathisia. Notably, all MD relate to deregulation of the dopamine system. Objective: This study aimed to replicate previously reported associations in candidate genes for acute and tardive antipsychotic-induced MD in a young Caucasian sample. Methods: In 402 patients (median age 26 years), a total of 13 polymorphisms were genotyped in eight dopamine-related candidate genes selected a priori from the literature (regarding dopamine and serotonin receptors, dopamine degradation, and free radicals scavenging enzymes pathways). Results: Patients with MD used on average a higher haloperidol dose equivalent when compared to those without MD. The prevalence of MD was high and did not differ between first- and second-generation antipsychotics. Significant associations were found between (a) the TaqI_D polymorphism and akathisia (OR = 2.3, p = 0.001 for each extra C-allele) and (b) the −141C polymorphism and tardive dyskinesia (OR = 0.20, p = 0.001 for each extra Del allele). The other polymorphisms were not significantly associated with an MD. Conclusions: Two associations were found between genetic variation TaqI_D and the −141C polymorphisms in the DRD2 gene and antipsychotic-induced MD; one with acute akathisia and one with tardive dyskinesia. These were previously reported to be associated with tardive dyskinesia and acute parkinsonism, respectively. These results suggest that the contribution of these DRD2 gene variants in the vulnerability of antipsychotic-induced MD takes place in a more general or pleiotropic way. [ABSTRACT FROM AUTHOR]
Copyright of Psychopharmacology is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Psychology and Behavioral Sciences Collection
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: pbh
DbLabel: Psychology and Behavioral Sciences Collection
An: 70330440
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Association of two DRD2 gene polymorphisms with acute and tardive antipsychotic-induced movement disorders in young Caucasian patients.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Koning%2C+Jeroen%22">Koning, Jeroen</searchLink><br /><searchLink fieldCode="AR" term="%22Vehof%2C+Jelle%22">Vehof, Jelle</searchLink><br /><searchLink fieldCode="AR" term="%22Burger%2C+Huibert%22">Burger, Huibert</searchLink><br /><searchLink fieldCode="AR" term="%22Wilffert%2C+Bob%22">Wilffert, Bob</searchLink><br /><searchLink fieldCode="AR" term="%22Hadithy%2C+Asmar%22">Hadithy, Asmar</searchLink><br /><searchLink fieldCode="AR" term="%22Alizadeh%2C+Behrooz%22">Alizadeh, Behrooz</searchLink><br /><searchLink fieldCode="AR" term="%22Harten%2C+Peter%22">Harten, Peter</searchLink><br /><searchLink fieldCode="AR" term="%22Snieder%2C+Harold%22">Snieder, Harold</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Psychopharmacology%22">Psychopharmacology</searchLink>. Feb2012, Vol. 219 Issue 3, p727-736. 10p.
– Name: Subject
  Label: Subjects
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22Pharmacogenomics%22">Pharmacogenomics</searchLink><br /><searchLink fieldCode="DE" term="%22Serotonin%22">Serotonin</searchLink><br /><searchLink fieldCode="DE" term="%22Dopamine%22">Dopamine</searchLink><br /><searchLink fieldCode="DE" term="%22Schizophrenia%22">Schizophrenia</searchLink><br /><searchLink fieldCode="DE" term="%22Movement+disorders%22">Movement disorders</searchLink><br /><searchLink fieldCode="DE" term="%22Antipsychotic+agents%22">Antipsychotic agents</searchLink><br /><searchLink fieldCode="DE" term="%22Genetic+polymorphisms%22">Genetic polymorphisms</searchLink><br /><searchLink fieldCode="DE" term="%22White+people%22">White people</searchLink><br /><searchLink fieldCode="DE" term="%22Health%22">Health</searchLink>
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: Rationale: Pharmacogenetic studies on antipsychotic-induced movement disorders (MD) in schizophrenia so far have focused mainly on tardive dyskinesia. Only a few examined the more acute antipsychotic-induced MD such as parkinsonism and akathisia. Notably, all MD relate to deregulation of the dopamine system. Objective: This study aimed to replicate previously reported associations in candidate genes for acute and tardive antipsychotic-induced MD in a young Caucasian sample. Methods: In 402 patients (median age 26 years), a total of 13 polymorphisms were genotyped in eight dopamine-related candidate genes selected a priori from the literature (regarding dopamine and serotonin receptors, dopamine degradation, and free radicals scavenging enzymes pathways). Results: Patients with MD used on average a higher haloperidol dose equivalent when compared to those without MD. The prevalence of MD was high and did not differ between first- and second-generation antipsychotics. Significant associations were found between (a) the TaqI_D polymorphism and akathisia (OR = 2.3, p = 0.001 for each extra C-allele) and (b) the −141C polymorphism and tardive dyskinesia (OR = 0.20, p = 0.001 for each extra Del allele). The other polymorphisms were not significantly associated with an MD. Conclusions: Two associations were found between genetic variation TaqI_D and the −141C polymorphisms in the DRD2 gene and antipsychotic-induced MD; one with acute akathisia and one with tardive dyskinesia. These were previously reported to be associated with tardive dyskinesia and acute parkinsonism, respectively. These results suggest that the contribution of these DRD2 gene variants in the vulnerability of antipsychotic-induced MD takes place in a more general or pleiotropic way. [ABSTRACT FROM AUTHOR]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: <i>Copyright of Psychopharmacology is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=70330440
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s00213-011-2394-1
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 10
        StartPage: 727
    Subjects:
      – SubjectFull: Pharmacogenomics
        Type: general
      – SubjectFull: Serotonin
        Type: general
      – SubjectFull: Dopamine
        Type: general
      – SubjectFull: Schizophrenia
        Type: general
      – SubjectFull: Movement disorders
        Type: general
      – SubjectFull: Antipsychotic agents
        Type: general
      – SubjectFull: Genetic polymorphisms
        Type: general
      – SubjectFull: White people
        Type: general
      – SubjectFull: Health
        Type: general
    Titles:
      – TitleFull: Association of two DRD2 gene polymorphisms with acute and tardive antipsychotic-induced movement disorders in young Caucasian patients.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Koning, Jeroen
      – PersonEntity:
          Name:
            NameFull: Vehof, Jelle
      – PersonEntity:
          Name:
            NameFull: Burger, Huibert
      – PersonEntity:
          Name:
            NameFull: Wilffert, Bob
      – PersonEntity:
          Name:
            NameFull: Hadithy, Asmar
      – PersonEntity:
          Name:
            NameFull: Alizadeh, Behrooz
      – PersonEntity:
          Name:
            NameFull: Harten, Peter
      – PersonEntity:
          Name:
            NameFull: Snieder, Harold
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 02
              Text: Feb2012
              Type: published
              Y: 2012
          Identifiers:
            – Type: issn-print
              Value: 00333158
          Numbering:
            – Type: volume
              Value: 219
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Psychopharmacology
              Type: main
ResultId 1